Skip to content
10-Q

Quarterly Report

Adaptive Biotechnologies Corp ADPT

0001193125-26-206546

← back to feed
Filed
May 5, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 160.04M sh
Shares Diluted Q1 2026 · Mar 31, 2026 155.52M sh
Shares Diluted Q1 2026 · Mar 31, 2025 149.2M sh
Capex Q1 2026 · Mar 31, 2026 $796K
Capex Q1 2026 · Mar 31, 2025 $1.26M
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$9.54M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$28.48M
Long Term Debt Q1 2026 · Mar 31, 2026 $124.75M
Long Term Debt Q1 2026 · Dec 31, 2025 $126.57M
Short Term Debt Q1 2026 · Mar 31, 2026 $5.8M
Short Term Debt Q1 2026 · Dec 31, 2025 $4.64M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $77.58M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $70.5M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $50.65M
Stockholders Equity Q1 2026 · Mar 31, 2026 $216.34M
Stockholders Equity Q1 2026 · Dec 31, 2025 $218.79M
Current Liabilities Q1 2026 · Mar 31, 2026 $87.01M
Current Liabilities Q1 2026 · Dec 31, 2025 $89.92M
Total Liabilities Q1 2026 · Mar 31, 2026 $281.7M
Total Liabilities Q1 2026 · Dec 31, 2025 $287.74M
Current Assets Q1 2026 · Mar 31, 2026 $291.81M
Current Assets Q1 2026 · Dec 31, 2025 $300.19M
Total Assets Q1 2026 · Mar 31, 2026 $505.94M
Total Assets Q1 2026 · Dec 31, 2025 $512.74M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.13
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.20
Eps Basic Q1 2026 · Mar 31, 2026 −$0.13
Eps Basic Q1 2026 · Mar 31, 2025 −$0.20
Sga Expense Q1 2026 · Mar 31, 2026 $20.98M
Sga Expense Q1 2026 · Mar 31, 2025 $17.4M
Rd Expense Q1 2026 · Mar 31, 2026 $23.62M
Rd Expense Q1 2026 · Mar 31, 2025 $24.2M
Net Income Q1 2026 · Mar 31, 2026 −$20.03M
Net Income Q1 2026 · Mar 31, 2025 −$29.85M
Operating Income Q1 2026 · Mar 31, 2026 −$19.21M
Operating Income Q1 2026 · Mar 31, 2025 −$29.6M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $18.71M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $16.98M
Revenue Q1 2026 · Mar 31, 2026 $70.87M
Revenue Q1 2026 · Mar 31, 2025 $52.44M